SGLT2 inhibitor treatment may now be considered in broader T2DM population

AHA 2018 - Chicago, IL, VS

3' education - Nov. 11, 2018 - Steve Wiviott, MD - Boston, MA, VS.

Educational information

This video was recorded at the congress of the American Heart Association on November 10, 2018, in Chicago, IL, USA.

Faculty

Steve Wiviott, MD, Brigham and Women's Hospital, Boston, MA, VS.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of the DECLARE TIMI-58 results

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.